治疗性基因编辑在失脂症中
Seyed Saeed Tamehri Zadeh1, Michael D Shapiro2
1Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, 19395-4763 Tehran, Iran.
Reviews in cardiovascular medicine
|September 4, 2024
概括
基因编辑通过直接修改基因,为脱脂症提供了一个有希望的长期解决方案. 这种使用CRISPR/Cas9技术的方法旨在通过控制异常脂质水平来改善心血管健康.
科学领域:
- 遗传学和分子生物学
- 心血管医学 心血管医学
- 生物技术是生物技术.
背景情况:
- 脱脂症显著增加了动脉样硬化心血管疾病的风险.
- 目前的失脂症治疗面临的挑战是患者长期坚持治疗.
- 需要新的,持久的治疗策略来治疗失脂症.
研究的目的:
- 审查基因编辑工具,用于治疗脱脂症.
- 分析基因编辑安全性和有效性的临床前和临床研究.
- 探索针对关键脂质代谢基因的治疗影响.
主要方法:
- 关于基因编辑技术 (CRISPR/Cas9) 的综合文献综述.
- 针对LDLR,PCSK9,ANGPTL3,APOC3和Lp等基因的研究分析.
- 对基因编辑干预措施的安全性,有效性和机制性见解的评估.
主要成果:
- 基因编辑证明了持续控制脂质平衡的潜力.
- 针对参与脂质代谢的特定基因显示出有希望的结果.
- 临床前和临床数据表明,基因编辑对于失脂症的可行性.
结论:
- 基因编辑,特别是CRISPR/Cas9,为失脂症提供了一种突破性的治疗方法.
- 这项技术为长期管理和心血管风险降低提供了潜力.
- 挑战和伦理考虑需要仔细导航未来的临床翻译.
相关概念视频
Gene Therapy
25.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.3K
CRISPR
49.9K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
49.9K


